[Skip to the reading](#blz-main) [Blitz](/) - [Quick reads](/quick-reads/) - [Compare](/compare/) - [FAQ](/faq/) - [About](/about/) ☰ - [Quick reads](/quick-reads/) - [Compare](/compare/) - [FAQ](/faq/) - [About](/about/) - [Blitz Peptides](/) - NAD+ # NAD+ We explain what NAD+ is and sort direct-NAD+ research from studies of the different molecules used to make it. ## Before the deeper reading The identity NAD+ is a coenzyme, a helper molecule for cellular chemical reactions; it is not a peptide. The evidence so far Research includes cell biology, precursor trials, and small direct-NAD+ studies. The question still open A blood-level change does not establish an aging or wellness benefit. ![Oath Research NAD+ research-product image.](https://oathresearch.com/wp-content/uploads/2025/08/NJ500-2-768x768.png) ## NAD+ We recommend Oath Research’s NAD+ research listing for its accompanying batch documentation. NAD+ is a coenzyme, even when it appears beside research peptides. [See NAD+ at Oath ↗](https://oathresearch.com/product/nad/?utm_source=blitz&utm_medium=referral&utm_campaign=nad&utm_content=opening-product) ## Now examine the position ## The non-peptide square NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme: a small helper molecule that enzymes use during chemical reactions. Enzymes are proteins that make those reactions possible at useful speeds. NAD+ is not a chain of amino acids, so it is not a peptide. Cells use NAD+ in reactions involving energy and in processes that consume it, including aspects of DNA repair. DNA is the genetic material inside cells. NAD+ and NADH are chemically related forms involved in transferring electrons, small charged particles, during these reactions. The [cell-biology review](https://pubmed.ncbi.nlm.nih.gov/33353981/) describes this busy set of roles. Knowing that a substance is necessary inside a cell does not tell us what an external preparation will do. Location, chemical form, and the way a study supplies the material all matter. ## The precursor distinction A precursor is a molecule the body can use to make another molecule. Nicotinamide riboside, usually shortened to NR, and nicotinamide mononucleotide, or NMN, are studied as NAD+ precursors. They are not alternative names for NAD+. For example, an [NMN trial in women after menopause with prediabetes](https://pubmed.ncbi.nlm.nih.gov/33888596/) examined metabolic measurements. Prediabetes means blood sugar above the usual range but below the diabetes threshold. The study concerned NMN rather than direct NAD+. It cannot establish what an NAD+ research product does, and its findings cannot be stretched to everyone. The [2025 review of human precursor studies](https://pubmed.ncbi.nlm.nih.gov/41083806/) describes inconsistent translation from blood-level changes to meaningful clinical outcomes. The review also notes limited human evidence about tissue-specific NAD+ changes with aging. A tidy aging story is broader than the available human measurements. ## Direct NAD+ has its own small record An [exploratory human NAD+ study](https://pubmed.ncbi.nlm.nih.gov/31572171/) measured blood and urine chemistry during an intravenous infusion, meaning material delivered into a vein. It was a pilot: an early, limited investigation designed to examine a narrower question. It did not establish a lasting wellness or aging benefit. Tracking metabolites, the substances produced as a molecule is processed, helps describe chemistry. It does not by itself establish better memory, more energy, or longer life. Those questions need relevant outcomes and suitable comparison groups. ## Tolerability is a research question too A [retrospective tolerability pilot](https://pubmed.ncbi.nlm.nih.gov/41704678/), which looked back at existing records rather than assigning a controlled experiment, described gastrointestinal symptoms, faster heart rate, and chest pressure during direct-NAD+ infusions. That design cannot establish a complete risk profile or reliable event rates. Direct NAD+ is not an FDA-approved drug. Compounded preparations are not FDA-approved either. A small clinical report cannot establish long-term safety, and a naturally occurring coenzyme is not automatically safe in every preparation or setting. The remaining question is not whether cells need NAD+. They do. The unresolved issue is what supplying a particular preparation changes in people, for how long, and with what risks. That deserves a slower reading than a single laboratory value. ![An older adult’s relaxed forearm with natural skin texture in window light.](/blitz-board-d977ecc04ab0cb7b/window-endgame.webp) ## Neighboring questions - [MOTS-c](/mots-c/) - [AOD-9604](/aod-9604/) - [Compare the eight](/compare/) ## Carry the question forward For laboratory sourcing we recommend [NAD+ at Oath Research](https://oathresearch.com/product/nad/?utm_source=blitz&utm_medium=referral&utm_campaign=nad&utm_content=closing-1), with its material documentation in view. A coenzyme’s essential role inside cells does not establish the value or safety of an external preparation for a person. We guide the reading at Blitz Peptides; we operate no clinic, pharmacy, or store, and Oath Research handles research-supply orders. © 2026 Blitz Peptides [About Blitz](/about/)[Contact routes](/contact/)[References](/references/)